Cost-effectiveness of genotyping in inherited arrhythmia syndromes: are we getting value for the money?

Circ Arrhythm Electrophysiol. 2009 Feb;2(1):1-3. doi: 10.1161/CIRCEP.109.849000.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Arrhythmias, Cardiac / diagnosis*
  • Arrhythmias, Cardiac / economics
  • Arrhythmias, Cardiac / genetics*
  • Atrioventricular Block / diagnosis
  • Atrioventricular Block / genetics
  • Brugada Syndrome / diagnosis
  • Brugada Syndrome / genetics
  • Cost-Benefit Analysis
  • Genetic Predisposition to Disease
  • Genetic Testing* / economics
  • Health Care Costs
  • Health Priorities
  • Health Services Accessibility
  • Humans
  • Insurance, Health, Reimbursement
  • Ion Channels / genetics*
  • Long QT Syndrome / diagnosis
  • Long QT Syndrome / genetics
  • Mass Screening / economics
  • Mass Screening / methods*
  • Patient Selection*
  • Phenotype
  • Predictive Value of Tests
  • Tachycardia, Ventricular / diagnosis
  • Tachycardia, Ventricular / genetics

Substances

  • Ion Channels